Khalil Ahmed Kaid

Khalil Kaid practices at Access Medicine Nj in Newark, New Jersey.

Khalil Kaid's NPI, 1285651109, was assigned on July 16, 2006. Khalil Kaid holds New Jersey license 25MA08008500.

Khalil Kaid's primary practice is Access Medicine Nj, at 228 Lafayette St Fl 5 Fl 5, Newark, NJ 07105. The practice phone is (973) 491-5222.

Khalil Kaid's primary practice is Access Medicine Nj in Newark, New Jersey. Khalil Kaid is also affiliated with Newark Beth Israel Medical Center. The medical group on file is Access Medicine NJ. Dmand AI also links Khalil Kaid to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Khalil Kaid practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Khalil Kaid's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Khalil Kaid is licensed in New Jersey.

CMS data shows 2,289 Medicare services from Khalil Kaid across 15 procedure codes in 2024, for 430 Medicare patients. Medicare paid $247,425 for them.

CMS counts 430 Medicare patients who saw Khalil Kaid in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Khalil Kaid's median patient age at 68, with 51% women.

In 2024, Khalil Kaid wrote 2,218 Medicare Part D claims for 475 patients. 87% of them were for generic drugs. CMS names the drug for 1,912 of them, across 39 drugs with 11 or more claims each, at $277,001 in total drug cost. In 2023, CMS named 3,233 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Khalil Kaid for performance year 2024, reported individually. Khalil Kaid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Khalil Kaid as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Khalil Kaid in 2016. Khalil Kaid's most frequent co-authors are Najam Wasty, MD, Manjusha Anna, MD and Spas V. Kotev, MD.

CMS Open Payments shows 572 general payments to Khalil Kaid from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $8,939.